Pharmafile Logo

Gower Publishing

- PMLiVE

To support patient-centricity in clinical trials, look to rare disease communities

How patients are seeking new treatment options that will advance the care of their communities

- PMLiVE

Ipsen’s Bylvay approved by FDA for severe itching due to Alagille syndrome

As many as 88% of patients living with the condition experience severe pruritus

- PMLiVE

Merck’s efinopegdutide shows promise in nonalcoholic fatty liver disease

The candidate was recently granted FDA fast track designation for a severe form of NAFLD

- PMLiVE

Almirall survey reveals limited knowledge of most common precancerous skin condition

Up to 80% of squamous cell carcinomas develop from actinic keratosis lesions

- PMLiVE

Havas reveals new brand architecture and visual identity

The agency will bring its branded networks and operating companies under one shared identity

- PMLiVE

Inizio appoints Shauna Aherne as president of medical excellence

Aherne has two decades of leadership experience in the pharmaceutical industry

- PMLiVE

The omnichannel conundrum

Why embracing imperfection is key to success

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links